Current Status of Dopamine Agonists in Parkinson??s Disease Management
- 1 September 1993
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 46 (3) , 384-393
- https://doi.org/10.2165/00003495-199346030-00005
Abstract
The occurrence of late side effects of long term levodopa therapy (fluctuations in motor performance, abnormal movements, and symptoms unresponsive to dihydroxyphenylalanine) led to the search for...Keywords
This publication has 43 references indexed in Scilit:
- Dopamine agonists in Parkinson's disease: a look at apomorphineFundamental & Clinical Pharmacology, 1993
- Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgeryThe Lancet, 1992
- SelegilineDrugs & Aging, 1991
- Apomorphine test in parkinsonian syndromesThe Lancet, 1990
- Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromesThe Lancet, 1990
- PergolideDrugs, 1990
- Overcoming pharmacokinetic problems in the treatment of parkinson's diseaseMovement Disorders, 1989
- SUBCUTANEOUS APOMORPHINE IN PARKINSON'S DISEASEThe Lancet, 1988
- Clinical Pharmacokinetics of Anti-Parkinsonian DrugsClinical Pharmacokinetics, 1987
- Drugs Affecting Movement DisordersAnnual Review of Pharmacology and Toxicology, 1987